- Home
- OCGN vs YDDL Comparison
OCGN vs YDDL Comparison
Compare OCGN & YDDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCGN
- YDDL
- Stock Information
- Founded
- OCGN 2013
- YDDL 2014
- Country
- OCGN United States
- YDDL Philippines
- Employees
- OCGN N/A
- YDDL N/A
- Industry
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- YDDL Industrial Specialties
- Sector
- OCGN Health Care
- YDDL Consumer Discretionary
- Exchange
- OCGN Nasdaq
- YDDL Nasdaq
- Market Cap
- OCGN 321.7M
- YDDL 275.4M
- IPO Year
- OCGN N/A
- YDDL 2025
- Fundamental
- Price
- OCGN $1.19
- YDDL $5.21
- Analyst Decision
- OCGN Strong Buy
- YDDL
- Analyst Count
- OCGN 2
- YDDL 0
- Target Price
- OCGN $7.00
- YDDL N/A
- AVG Volume (30 Days)
- OCGN 3.2M
- YDDL 117.2K
- Earning Date
- OCGN 11-05-2025
- YDDL 11-17-2025
- Dividend Yield
- OCGN N/A
- YDDL N/A
- EPS Growth
- OCGN N/A
- YDDL 311.19
- EPS
- OCGN N/A
- YDDL 0.15
- Revenue
- OCGN $5,370,000.00
- YDDL $62,922,700.00
- Revenue This Year
- OCGN N/A
- YDDL N/A
- Revenue Next Year
- OCGN N/A
- YDDL N/A
- P/E Ratio
- OCGN N/A
- YDDL $33.09
- Revenue Growth
- OCGN 14.26
- YDDL 118.15
- 52 Week Low
- OCGN $0.52
- YDDL $3.61
- 52 Week High
- OCGN $1.90
- YDDL $8.89
- Technical
- Relative Strength Index (RSI)
- OCGN 36.58
- YDDL N/A
- Support Level
- OCGN $1.14
- YDDL N/A
- Resistance Level
- OCGN $1.22
- YDDL N/A
- Average True Range (ATR)
- OCGN 0.08
- YDDL 0.00
- MACD
- OCGN -0.01
- YDDL 0.00
- Stochastic Oscillator
- OCGN 28.79
- YDDL 0.00
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
About YDDL One and One Green Technologies. Inc Class A Ordinary Shares
One and one Green Technologies Inc is engaged in recycling, production, and trading of recycled scrap metals in the Republic of Philippines. The company process raw materials and generate final products that include copper alloy ingot, aluminum scrapes, plastic beads, and others. It provides economical and flexible solutions to the challenges of electronic waste, metal scrap and industrial recycling. By providing lower-cost alternatives for processing recycled materials, It is not only Contributing to environmental sustainability but also highlight its role as a modern and specialized recycling company.